Tuesday, May 31, 2016

OV LiPlaCis™ - First Screened Breast Cancer Patient Dosed in First Prospective Study

… 1000 patients have had their tumors DRP-screened beforehand. The included patients … of cancer due to its documented efficacy in a number of tumour … ™, for Breast Cancer, Irofulven, developed from a fungus, for Prostate Cancer, and APO010 …

No comments:

Post a Comment